M&A Update – January 19

– CNCE to be acquired by Sun Pharmaceutical Industries for $8.00 cash per share + CVR for up to $3.50, 15.9% premium, $576 million
– IAA / RBA / Luxor Capital (owns 4.2 million RBA shares, 3.6%) filed prelim proxy to oppose merger, plans to solicit proxies against deal, claims it destroys $1.8 billion of shareholder value
– FRII.to / Foodtastic filed management information circular, vote Feb 8, closing Feb